For Matthew Schissler, Net Worth Is About Contribution, Not Cash

In every sector he's worked in, Matthew Schissler has been early. Early to see the opportunity. Early to act. Early to move when others hesitated.

It's part of what defines his career-an ability to commit to a long view when others chase short-term outcomes.

Schissler first gained recognition in biotech. In 2003, he founded Cord Blood America, Inc., a stem cell storage company built around a simple idea: that families would want access to umbilical cord blood for future medical use. At the time, the market was still young. Many questioned the concept. But Schissler committed. He led the company through major acquisitions, added international partnerships, and relocated its headquarters to scale more efficiently.

Under his leadership, Cord Blood America grew to include operations in Germany, Argentina, and Asia. It acquired key competitors in the U.S. and developed a network of labs and storage facilities serving thousands of families.

His focus wasn't just on growth-it was on making the idea viable.
"I've always believed in solving real problems," Schissler says. "If a business can do that, the value will come."

That idea has shaped everything since. After his time at CBAI, Schissler transitioned into private investment. He began managing funds that focus on companies with strong fundamentals and untapped potential. These are often businesses overlooked by larger firms-too early, too complex, or too unconventional.

But Schissler sees those qualities as strengths.

"If everyone already believes in something, the upside is gone," he says. "I look for the places where belief is still forming. That's where vision matters most."

He also founded Work Your Core Investments, a fund focused on performance-driven businesses in the fitness and wellness space. The companies in his portfolio share a theme: long-term utility. They're built to last, not to flip.

Despite years of growth and success, Schissler rarely talks about wealth. He doesn't lead with numbers. He doesn't promote lifestyle.

"Money's not the goal," he says. "It's a resource. You use it to reinforce what matters-to protect your time, to choose who you work with, to back ideas you believe in."

That mindset extends to risk. Schissler believes risk isn't something to avoid-it's something to understand. Throughout his career, he's taken strategic risks to scale businesses, relocate teams, or enter new markets. But each move was based on logic, timing, and conviction-not ego.

"You learn more from the losses than the wins," he says. "But only if you stay honest about why you made the choice in the first place."

Alongside his investment work, Schissler has served on multiple boards, including Aztec Airways and nonprofit science institutions. He approaches board service with the same lens: offer insight, support smart decisions, and keep the long view in focus.

At this stage in his career, Schissler's goals are no longer tied to visibility or reputation. They're tied to legacy. Not in the traditional sense-but in how his work shapes the people, ideas, and companies around him.

"Value is what you leave behind when you walk away," he says. "Did you make something stronger? Did you help someone move forward? That's what matters."

For those who try to measure worth by external standards, Schissler offers a different framework: clarity, contribution, and consistency.
"You won't always control the outcome," he says. "But you control how you show up. If you keep showing up with integrity, you'll build something that lasts. And that's worth more than anything you can measure."

522. W Riverside Ave, Ste 6961, Spokane, WA 99201

Matthew Schissler is a private investor and entrepreneur with a track record in biotech, private equity, and franchise development.

This release was published on openPR.